Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceuticals, Inc. is a risky bet given it's low Altman Z-score. Companies with a low Altman Z-score have a higher chance of going bankrupt within the next 2 years. This stock has a reasonable momentum. Catalyst Pharmaceuticals, Inc. has good growth characteristics. Catalyst Pharmaceuticals, Inc. is not very popular among insiders. Catalyst Pharmaceuticals, Inc. is a mediocre stock to choose.
Log in to see more information.
Catalyst Pharmaceuticals is a biopharmaceutical company, which engages in the development and commer...

News

Santhera Announces Half-Year 2024 Financial Results and Provides Corporate Update
Santhera Announces Half-Year 2024 Financial Results and Provides Corporate Update

Globe Newswire Ad hoc announcement pursuant to Art. 53 LR A conference call will be held on September 12, 2024, at 14:30 CEST / 13:30 BST / 08:30 EDT. Details are at the end of this news release. Revenue from...\n more…

Why Is Catalyst (CPRX) Up 8.3% Since Last Earnings Report?
Why Is Catalyst (CPRX) Up 8.3% Since Last Earnings Report?

Zacks Investment Research A month has gone by since the last earnings report for Catalyst Pharmaceutical (CPRX). Shares have added about 8.3% in that time frame, outperforming the S&P 500.Will the recent positive trend...\n more…

Here's How Much a $1000 Investment in Catalyst Pharmaceutical Made 10 Years Ago Would Be Worth Today
Here's How Much a $1000 Investment in Catalyst Pharmaceutical Made 10 Years Ago Would Be Worth Today

Zacks Investment Research For most investors, how much a stock's price changes over time is important. This factor can impact your investment portfolio as well as help you compare investment results across sectors and...\n more…

Don't Ignore The Insider Selling In Catalyst Pharmaceuticals
Don't Ignore The Insider Selling In Catalyst Pharmaceuticals

Simply Wall St We wouldn't blame Catalyst Pharmaceuticals, Inc. ( NASDAQ:CPRX ) shareholders if they were a little worried about the...\n more…

Catalyst Pharmaceuticals to Participate in Upcoming Investor Conferences
Catalyst Pharmaceuticals to Participate in Upcoming Investor Conferences

Globe Newswire CORAL GABLES, Fla., Aug. 20, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing...\n more…

Here's How Much You'd Have If You Invested $1000 in Catalyst Pharmaceutical a Decade Ago
Here's How Much You'd Have If You Invested $1000 in Catalyst Pharmaceutical a Decade Ago

Zacks Investment Research For most investors, how much a stock's price changes over time is important. This factor can impact your investment portfolio as well as help you compare investment results across sectors and...\n more…